Global Prostate Cancer Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
According to APO Research, The global Prostate Cancer Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Prostate Cancer Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate Cancer Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Prostate Cancer Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Prostate Cancer Diagnostics segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prostate Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostate Cancer Diagnostics industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Diagnosticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
According to APO Research, The global Prostate Cancer Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Prostate Cancer Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Prostate Cancer Diagnostics include OPKO, Genomic Health, Abbott, Beckman Coulter, Siemens Healthcare, bioMeriux, Roche, MDx Health and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Prostate Cancer Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate Cancer Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Prostate Cancer Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Prostate Cancer Diagnostics segment by Company
- OPKO
- Genomic Health
- Abbott
- Beckman Coulter
- Siemens Healthcare
- bioMeriux
- Roche
- MDx Health
- DiaSorin
- Myriad Genetics
- Ambry Genetics
- Tumor Biomarker Tests
- Imaging
- Biopsy
- Other
- Age Below 55
- Age 55-75
- Age Above 75
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prostate Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostate Cancer Diagnostics industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Diagnosticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Age Below
1.3.3 Age 55-75
1.3.4 Age Above
1.4 Global Market Growth Prospects
1.5 Global Prostate Cancer Diagnostics Growth Trends by Region
1.5.1 Global Prostate Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Prostate Cancer Diagnostics Market Size by Region (2019-2024)
1.5.3 Prostate Cancer Diagnostics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET DYNAMICS
2.1 Prostate Cancer Diagnostics Industry Trends
2.2 Prostate Cancer Diagnostics Industry Drivers
2.3 Prostate Cancer Diagnostics Industry Opportunities and Challenges
2.4 Prostate Cancer Diagnostics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Prostate Cancer Diagnostics Revenue by Company (2019-2024)
3.2 Global Prostate Cancer Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Prostate Cancer Diagnostics Key Company Head office and Area Served
3.4 Global Prostate Cancer Diagnostics Company, Product Type & Application
3.5 Global Prostate Cancer Diagnostics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Prostate Cancer Diagnostics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
3.6.3 2023 Prostate Cancer Diagnostics Tier 1, Tier 2, and Tier
4 PROSTATE CANCER DIAGNOSTICS MARKET BY TYPE
4.1 Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Prostate Cancer Diagnostics Market Size by Type (2019-2030)
4.3 Global Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
5 PROSTATE CANCER DIAGNOSTICS MARKET BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Prostate Cancer Diagnostics Market Size by Application (2019-2030)
5.3 Global Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 OPKO
6.1.1 OPKO Comapny Information
6.1.2 OPKO Business Overview
6.1.3 OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 OPKO Prostate Cancer Diagnostics Product Portfolio
6.1.5 OPKO Recent Developments
6.2 Genomic Health
6.2.1 Genomic Health Comapny Information
6.2.2 Genomic Health Business Overview
6.2.3 Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Genomic Health Prostate Cancer Diagnostics Product Portfolio
6.2.5 Genomic Health Recent Developments
6.3 Abbott
6.3.1 Abbott Comapny Information
6.3.2 Abbott Business Overview
6.3.3 Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Abbott Prostate Cancer Diagnostics Product Portfolio
6.3.5 Abbott Recent Developments
6.4 Beckman Coulter
6.4.1 Beckman Coulter Comapny Information
6.4.2 Beckman Coulter Business Overview
6.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
6.4.5 Beckman Coulter Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Comapny Information
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
6.5.5 Siemens Healthcare Recent Developments
6.6 bioMeriux
6.6.1 bioMeriux Comapny Information
6.6.2 bioMeriux Business Overview
6.6.3 bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 bioMeriux Prostate Cancer Diagnostics Product Portfolio
6.6.5 bioMeriux Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Roche Prostate Cancer Diagnostics Product Portfolio
6.7.5 Roche Recent Developments
6.8 MDx Health
6.8.1 MDx Health Comapny Information
6.8.2 MDx Health Business Overview
6.8.3 MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 MDx Health Prostate Cancer Diagnostics Product Portfolio
6.8.5 MDx Health Recent Developments
6.9 DiaSorin
6.9.1 DiaSorin Comapny Information
6.9.2 DiaSorin Business Overview
6.9.3 DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 DiaSorin Prostate Cancer Diagnostics Product Portfolio
6.9.5 DiaSorin Recent Developments
6.10 Myriad Genetics
6.10.1 Myriad Genetics Comapny Information
6.10.2 Myriad Genetics Business Overview
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
6.10.5 Myriad Genetics Recent Developments
6.11 Ambry Genetics
6.11.1 Ambry Genetics Comapny Information
6.11.2 Ambry Genetics Business Overview
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
6.11.5 Ambry Genetics Recent Developments
7 NORTH AMERICA
7.1 North America Prostate Cancer Diagnostics Market Size (2019-2030)
7.2 North America Prostate Cancer Diagnostics Market Size by Type
7.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2019-2024)
7.2.2 North America Prostate Cancer Diagnostics Market Size by Type (2025-2030)
7.2.3 North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)
7.3 North America Prostate Cancer Diagnostics Market Size by Application
7.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2019-2024)
7.3.2 North America Prostate Cancer Diagnostics Market Size by Application (2025-2030)
7.3.3 North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)
7.4 North America Prostate Cancer Diagnostics Market Size by Country
7.4.1 North America Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
7.4.3 North America Prostate Cancer Diagnostics Market Size by Country (2025-2030)
7.4.4 North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Prostate Cancer Diagnostics Market Size (2019-2030)
8.2 Europe Prostate Cancer Diagnostics Market Size by Type
8.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024)
8.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030)
8.2.3 Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)
8.3 Europe Prostate Cancer Diagnostics Market Size by Application
8.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024)
8.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030)
8.3.3 Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)
8.4 Europe Prostate Cancer Diagnostics Market Size by Country
8.4.1 Europe Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
8.4.3 Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030)
8.4.4 Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Prostate Cancer Diagnostics Market Size (2019-2030)
9.2 China Prostate Cancer Diagnostics Market Size by Type
9.2.1 China Prostate Cancer Diagnostics Market Size by Type (2019-2024)
9.2.2 China Prostate Cancer Diagnostics Market Size by Type (2025-2030)
9.2.3 China Prostate Cancer Diagnostics Market Share by Type (2019-2030)
9.3 China Prostate Cancer Diagnostics Market Size by Application
9.3.1 China Prostate Cancer Diagnostics Market Size by Application (2019-2024)
9.3.2 China Prostate Cancer Diagnostics Market Size by Application (2025-2030)
9.3.3 China Prostate Cancer Diagnostics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Prostate Cancer Diagnostics Market Size (2019-2030)
10.2 Asia Prostate Cancer Diagnostics Market Size by Type
10.2.1 Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024)
10.2.2 Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030)
10.2.3 Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)
10.3 Asia Prostate Cancer Diagnostics Market Size by Application
10.3.1 Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024)
10.3.2 Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030)
10.3.3 Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)
10.4 Asia Prostate Cancer Diagnostics Market Size by Country
10.4.1 Asia Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Prostate Cancer Diagnostics Market Size by Country (2019-2024)
10.4.3 Asia Prostate Cancer Diagnostics Market Size by Country (2025-2030)
10.4.4 Asia Prostate Cancer Diagnostics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Prostate Cancer Diagnostics Market Size (2019-2030)
11.2 MEALA Prostate Cancer Diagnostics Market Size by Type
11.2.1 MEALA Prostate Cancer Diagnostics Market Size by Type (2019-2024)
11.2.2 MEALA Prostate Cancer Diagnostics Market Size by Type (2025-2030)
11.2.3 MEALA Prostate Cancer Diagnostics Market Share by Type (2019-2030)
11.3 MEALA Prostate Cancer Diagnostics Market Size by Application
11.3.1 MEALA Prostate Cancer Diagnostics Market Size by Application (2019-2024)
11.3.2 MEALA Prostate Cancer Diagnostics Market Size by Application (2025-2030)
11.3.3 MEALA Prostate Cancer Diagnostics Market Share by Application (2019-2030)
11.4 MEALA Prostate Cancer Diagnostics Market Size by Country
11.4.1 MEALA Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Prostate Cancer Diagnostics Market Size by Country (2019-2024)
11.4.3 MEALA Prostate Cancer Diagnostics Market Size by Country (2025-2030)
11.4.4 MEALA Prostate Cancer Diagnostics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Age Below
1.3.3 Age 55-75
1.3.4 Age Above
1.4 Global Market Growth Prospects
1.5 Global Prostate Cancer Diagnostics Growth Trends by Region
1.5.1 Global Prostate Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Prostate Cancer Diagnostics Market Size by Region (2019-2024)
1.5.3 Prostate Cancer Diagnostics Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET DYNAMICS
2.1 Prostate Cancer Diagnostics Industry Trends
2.2 Prostate Cancer Diagnostics Industry Drivers
2.3 Prostate Cancer Diagnostics Industry Opportunities and Challenges
2.4 Prostate Cancer Diagnostics Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Prostate Cancer Diagnostics Revenue by Company (2019-2024)
3.2 Global Prostate Cancer Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Prostate Cancer Diagnostics Key Company Head office and Area Served
3.4 Global Prostate Cancer Diagnostics Company, Product Type & Application
3.5 Global Prostate Cancer Diagnostics Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Prostate Cancer Diagnostics Market CR5 and HHI
3.6.2 Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
3.6.3 2023 Prostate Cancer Diagnostics Tier 1, Tier 2, and Tier
4 PROSTATE CANCER DIAGNOSTICS MARKET BY TYPE
4.1 Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Prostate Cancer Diagnostics Market Size by Type (2019-2030)
4.3 Global Prostate Cancer Diagnostics Market Size Share by Type (2019-2030)
5 PROSTATE CANCER DIAGNOSTICS MARKET BY APPLICATION
5.1 Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Prostate Cancer Diagnostics Market Size by Application (2019-2030)
5.3 Global Prostate Cancer Diagnostics Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 OPKO
6.1.1 OPKO Comapny Information
6.1.2 OPKO Business Overview
6.1.3 OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 OPKO Prostate Cancer Diagnostics Product Portfolio
6.1.5 OPKO Recent Developments
6.2 Genomic Health
6.2.1 Genomic Health Comapny Information
6.2.2 Genomic Health Business Overview
6.2.3 Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Genomic Health Prostate Cancer Diagnostics Product Portfolio
6.2.5 Genomic Health Recent Developments
6.3 Abbott
6.3.1 Abbott Comapny Information
6.3.2 Abbott Business Overview
6.3.3 Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Abbott Prostate Cancer Diagnostics Product Portfolio
6.3.5 Abbott Recent Developments
6.4 Beckman Coulter
6.4.1 Beckman Coulter Comapny Information
6.4.2 Beckman Coulter Business Overview
6.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
6.4.5 Beckman Coulter Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Comapny Information
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
6.5.5 Siemens Healthcare Recent Developments
6.6 bioMeriux
6.6.1 bioMeriux Comapny Information
6.6.2 bioMeriux Business Overview
6.6.3 bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 bioMeriux Prostate Cancer Diagnostics Product Portfolio
6.6.5 bioMeriux Recent Developments
6.7 Roche
6.7.1 Roche Comapny Information
6.7.2 Roche Business Overview
6.7.3 Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Roche Prostate Cancer Diagnostics Product Portfolio
6.7.5 Roche Recent Developments
6.8 MDx Health
6.8.1 MDx Health Comapny Information
6.8.2 MDx Health Business Overview
6.8.3 MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 MDx Health Prostate Cancer Diagnostics Product Portfolio
6.8.5 MDx Health Recent Developments
6.9 DiaSorin
6.9.1 DiaSorin Comapny Information
6.9.2 DiaSorin Business Overview
6.9.3 DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 DiaSorin Prostate Cancer Diagnostics Product Portfolio
6.9.5 DiaSorin Recent Developments
6.10 Myriad Genetics
6.10.1 Myriad Genetics Comapny Information
6.10.2 Myriad Genetics Business Overview
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
6.10.5 Myriad Genetics Recent Developments
6.11 Ambry Genetics
6.11.1 Ambry Genetics Comapny Information
6.11.2 Ambry Genetics Business Overview
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
6.11.5 Ambry Genetics Recent Developments
7 NORTH AMERICA
7.1 North America Prostate Cancer Diagnostics Market Size (2019-2030)
7.2 North America Prostate Cancer Diagnostics Market Size by Type
7.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2019-2024)
7.2.2 North America Prostate Cancer Diagnostics Market Size by Type (2025-2030)
7.2.3 North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)
7.3 North America Prostate Cancer Diagnostics Market Size by Application
7.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2019-2024)
7.3.2 North America Prostate Cancer Diagnostics Market Size by Application (2025-2030)
7.3.3 North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)
7.4 North America Prostate Cancer Diagnostics Market Size by Country
7.4.1 North America Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
7.4.3 North America Prostate Cancer Diagnostics Market Size by Country (2025-2030)
7.4.4 North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Prostate Cancer Diagnostics Market Size (2019-2030)
8.2 Europe Prostate Cancer Diagnostics Market Size by Type
8.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024)
8.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030)
8.2.3 Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)
8.3 Europe Prostate Cancer Diagnostics Market Size by Application
8.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024)
8.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030)
8.3.3 Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)
8.4 Europe Prostate Cancer Diagnostics Market Size by Country
8.4.1 Europe Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
8.4.3 Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030)
8.4.4 Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Prostate Cancer Diagnostics Market Size (2019-2030)
9.2 China Prostate Cancer Diagnostics Market Size by Type
9.2.1 China Prostate Cancer Diagnostics Market Size by Type (2019-2024)
9.2.2 China Prostate Cancer Diagnostics Market Size by Type (2025-2030)
9.2.3 China Prostate Cancer Diagnostics Market Share by Type (2019-2030)
9.3 China Prostate Cancer Diagnostics Market Size by Application
9.3.1 China Prostate Cancer Diagnostics Market Size by Application (2019-2024)
9.3.2 China Prostate Cancer Diagnostics Market Size by Application (2025-2030)
9.3.3 China Prostate Cancer Diagnostics Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Prostate Cancer Diagnostics Market Size (2019-2030)
10.2 Asia Prostate Cancer Diagnostics Market Size by Type
10.2.1 Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024)
10.2.2 Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030)
10.2.3 Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)
10.3 Asia Prostate Cancer Diagnostics Market Size by Application
10.3.1 Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024)
10.3.2 Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030)
10.3.3 Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)
10.4 Asia Prostate Cancer Diagnostics Market Size by Country
10.4.1 Asia Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Prostate Cancer Diagnostics Market Size by Country (2019-2024)
10.4.3 Asia Prostate Cancer Diagnostics Market Size by Country (2025-2030)
10.4.4 Asia Prostate Cancer Diagnostics Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Prostate Cancer Diagnostics Market Size (2019-2030)
11.2 MEALA Prostate Cancer Diagnostics Market Size by Type
11.2.1 MEALA Prostate Cancer Diagnostics Market Size by Type (2019-2024)
11.2.2 MEALA Prostate Cancer Diagnostics Market Size by Type (2025-2030)
11.2.3 MEALA Prostate Cancer Diagnostics Market Share by Type (2019-2030)
11.3 MEALA Prostate Cancer Diagnostics Market Size by Application
11.3.1 MEALA Prostate Cancer Diagnostics Market Size by Application (2019-2024)
11.3.2 MEALA Prostate Cancer Diagnostics Market Size by Application (2025-2030)
11.3.3 MEALA Prostate Cancer Diagnostics Market Share by Application (2019-2030)
11.4 MEALA Prostate Cancer Diagnostics Market Size by Country
11.4.1 MEALA Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Prostate Cancer Diagnostics Market Size by Country (2019-2024)
11.4.3 MEALA Prostate Cancer Diagnostics Market Size by Country (2025-2030)
11.4.4 MEALA Prostate Cancer Diagnostics Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
LIST OF TABLES
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Key Players of Age Below 55
Table 8. Key Players of Age 55-75
Table 9. Key Players of Age Above 75
Table 10. Global Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Prostate Cancer Diagnostics Market Share by Region (2019-2024)
Table 13. Global Prostate Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Prostate Cancer Diagnostics Market Share by Region (2025-2030)
Table 15. Prostate Cancer Diagnostics Industry Trends
Table 16. Prostate Cancer Diagnostics Industry Drivers
Table 17. Prostate Cancer Diagnostics Industry Opportunities and Challenges
Table 18. Prostate Cancer Diagnostics Industry Restraints
Table 19. Global Prostate Cancer Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 20. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2024)
Table 21. Global Prostate Cancer Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 22. Global Prostate Cancer Diagnostics Key Company Head office and Area Served
Table 23. Global Prostate Cancer Diagnostics Company, Product Type & Application
Table 24. Global Prostate Cancer Diagnostics Company Commercialization Time
Table 25. Global Company Market Concentration Ratio (CR5 and HHI)
Table 26. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 27. Global Prostate Cancer Diagnostics Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 31. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 32. Global Prostate Cancer Diagnostics Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 36. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 37. OPKO Business Overview
Table 38. OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. OPKO Prostate Cancer Diagnostics Product Portfolio
Table 40. OPKO Recent Development
Table 41. Genomic Health Company Information
Table 42. Genomic Health Business Overview
Table 43. Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 45. Genomic Health Recent Development
Table 46. Abbott Company Information
Table 47. Abbott Business Overview
Table 48. Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Abbott Prostate Cancer Diagnostics Product Portfolio
Table 50. Abbott Recent Development
Table 51. Beckman Coulter Company Information
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 55. Beckman Coulter Recent Development
Table 56. Siemens Healthcare Company Information
Table 57. Siemens Healthcare Business Overview
Table 58. Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 60. Siemens Healthcare Recent Development
Table 61. bioMeriux Company Information
Table 62. bioMeriux Business Overview
Table 63. bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 65. bioMeriux Recent Development
Table 66. Roche Company Information
Table 67. Roche Business Overview
Table 68. Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Roche Prostate Cancer Diagnostics Product Portfolio
Table 70. Roche Recent Development
Table 71. MDx Health Company Information
Table 72. MDx Health Business Overview
Table 73. MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 75. MDx Health Recent Development
Table 76. DiaSorin Company Information
Table 77. DiaSorin Business Overview
Table 78. DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 80. DiaSorin Recent Development
Table 81. Myriad Genetics Company Information
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 85. Myriad Genetics Recent Development
Table 86. Ambry Genetics Company Information
Table 87. Ambry Genetics Business Overview
Table 88. Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 89. Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 90. Ambry Genetics Recent Development
Table 91. North America Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 92. North America Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 93. North America Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 94. North America Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 95. North America Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 97. North America Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 98. Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 99. Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 100. Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 101. Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 102. Europe Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 104. Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 105. China Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 106. China Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 107. China Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 108. China Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 109. Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 110. Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 111. Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 112. Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 113. Asia Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. Asia Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 115. Asia Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 116. MEALA Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 117. MEALA Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 118. MEALA Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 119. MEALA Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 120. MEALA Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 121. MEALA Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 122. MEALA Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 123. Research Programs/Design for This Report
Table 124. Authors List of This Report
Table 125. Secondary Sources
Table 126. Primary Sources
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Key Players of Age Below 55
Table 8. Key Players of Age 55-75
Table 9. Key Players of Age Above 75
Table 10. Global Prostate Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Prostate Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Prostate Cancer Diagnostics Market Share by Region (2019-2024)
Table 13. Global Prostate Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Prostate Cancer Diagnostics Market Share by Region (2025-2030)
Table 15. Prostate Cancer Diagnostics Industry Trends
Table 16. Prostate Cancer Diagnostics Industry Drivers
Table 17. Prostate Cancer Diagnostics Industry Opportunities and Challenges
Table 18. Prostate Cancer Diagnostics Industry Restraints
Table 19. Global Prostate Cancer Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 20. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2019-2024)
Table 21. Global Prostate Cancer Diagnostics Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 22. Global Prostate Cancer Diagnostics Key Company Head office and Area Served
Table 23. Global Prostate Cancer Diagnostics Company, Product Type & Application
Table 24. Global Prostate Cancer Diagnostics Company Commercialization Time
Table 25. Global Company Market Concentration Ratio (CR5 and HHI)
Table 26. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 27. Global Prostate Cancer Diagnostics Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 31. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 32. Global Prostate Cancer Diagnostics Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 36. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 37. OPKO Business Overview
Table 38. OPKO Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. OPKO Prostate Cancer Diagnostics Product Portfolio
Table 40. OPKO Recent Development
Table 41. Genomic Health Company Information
Table 42. Genomic Health Business Overview
Table 43. Genomic Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Genomic Health Prostate Cancer Diagnostics Product Portfolio
Table 45. Genomic Health Recent Development
Table 46. Abbott Company Information
Table 47. Abbott Business Overview
Table 48. Abbott Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Abbott Prostate Cancer Diagnostics Product Portfolio
Table 50. Abbott Recent Development
Table 51. Beckman Coulter Company Information
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. Beckman Coulter Prostate Cancer Diagnostics Product Portfolio
Table 55. Beckman Coulter Recent Development
Table 56. Siemens Healthcare Company Information
Table 57. Siemens Healthcare Business Overview
Table 58. Siemens Healthcare Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Siemens Healthcare Prostate Cancer Diagnostics Product Portfolio
Table 60. Siemens Healthcare Recent Development
Table 61. bioMeriux Company Information
Table 62. bioMeriux Business Overview
Table 63. bioMeriux Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. bioMeriux Prostate Cancer Diagnostics Product Portfolio
Table 65. bioMeriux Recent Development
Table 66. Roche Company Information
Table 67. Roche Business Overview
Table 68. Roche Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Roche Prostate Cancer Diagnostics Product Portfolio
Table 70. Roche Recent Development
Table 71. MDx Health Company Information
Table 72. MDx Health Business Overview
Table 73. MDx Health Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. MDx Health Prostate Cancer Diagnostics Product Portfolio
Table 75. MDx Health Recent Development
Table 76. DiaSorin Company Information
Table 77. DiaSorin Business Overview
Table 78. DiaSorin Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. DiaSorin Prostate Cancer Diagnostics Product Portfolio
Table 80. DiaSorin Recent Development
Table 81. Myriad Genetics Company Information
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Myriad Genetics Prostate Cancer Diagnostics Product Portfolio
Table 85. Myriad Genetics Recent Development
Table 86. Ambry Genetics Company Information
Table 87. Ambry Genetics Business Overview
Table 88. Ambry Genetics Prostate Cancer Diagnostics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 89. Ambry Genetics Prostate Cancer Diagnostics Product Portfolio
Table 90. Ambry Genetics Recent Development
Table 91. North America Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 92. North America Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 93. North America Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 94. North America Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 95. North America Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. North America Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 97. North America Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 98. Europe Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 99. Europe Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 100. Europe Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 101. Europe Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 102. Europe Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Europe Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 104. Europe Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 105. China Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 106. China Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 107. China Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 108. China Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 109. Asia Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 110. Asia Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 111. Asia Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 112. Asia Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 113. Asia Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. Asia Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 115. Asia Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 116. MEALA Prostate Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 117. MEALA Prostate Cancer Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 118. MEALA Prostate Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 119. MEALA Prostate Cancer Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 120. MEALA Prostate Cancer Diagnostics Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 121. MEALA Prostate Cancer Diagnostics Market Size by Country (2019-2024)
Table 122. MEALA Prostate Cancer Diagnostics Market Size by Country (2025-2030)
Table 123. Research Programs/Design for This Report
Table 124. Authors List of This Report
Table 125. Secondary Sources
Table 126. Primary Sources
LIST OF FIGURES
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prostate Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 4. Tumor Biomarker Tests Picture
Figure 5. Imaging Picture
Figure 6. Biopsy Picture
Figure 7. Other Picture
Figure 8. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Prostate Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Age Below 55 Picture
Figure 11. Age 55-75 Picture
Figure 12. Age Above 75 Picture
Figure 13. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 15. Global Prostate Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Years Considered
Figure 17. Global Prostate Cancer Diagnostics Market Share by Players in 2023
Figure 18. Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2019-2030)
Figure 22. Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2019-2030)
Figure 24. North America Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 25. North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 26. North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 27. North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 28. United States Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 29. Canada Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 31. Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 32. Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 33. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 34. Germany Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 35. France Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 36. U.K. Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 37. Italy Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 38. Russia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 40. China Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 41. China Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 42. China Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 43. Asia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 44. Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 45. Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 46. Asia Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 47. Japan Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 48. South Korea Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 49. China Taiwan Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 51. India Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 52. Australia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 53. MEALA Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 54. MEALA Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 55. MEALA Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 56. MEALA Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 57. Brazil Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 58. Mexico Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 59. Turkey Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 60. Israel Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 61. GCC Countries Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 62. Research Process
Figure 63. Key Executives Interviewed
Figure 1. Prostate Cancer Diagnostics Product Picture
Figure 2. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prostate Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 4. Tumor Biomarker Tests Picture
Figure 5. Imaging Picture
Figure 6. Biopsy Picture
Figure 7. Other Picture
Figure 8. Global Prostate Cancer Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Prostate Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Age Below 55 Picture
Figure 11. Age 55-75 Picture
Figure 12. Age Above 75 Picture
Figure 13. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 15. Global Prostate Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Years Considered
Figure 17. Global Prostate Cancer Diagnostics Market Share by Players in 2023
Figure 18. Global Top 5 and 10 Prostate Cancer Diagnostics Players Market Share by Revenue in 2023
Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Prostate Cancer Diagnostics Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2019-2030)
Figure 22. Global Prostate Cancer Diagnostics Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2019-2030)
Figure 24. North America Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 25. North America Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 26. North America Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 27. North America Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 28. United States Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 29. Canada Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 31. Europe Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 32. Europe Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 33. Europe Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 34. Germany Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 35. France Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 36. U.K. Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 37. Italy Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 38. Russia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 40. China Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 41. China Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 42. China Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 43. Asia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 44. Asia Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 45. Asia Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 46. Asia Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 47. Japan Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 48. South Korea Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 49. China Taiwan Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 51. India Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 52. Australia Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 53. MEALA Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 54. MEALA Prostate Cancer Diagnostics Market Share by Type (2019-2030)
Figure 55. MEALA Prostate Cancer Diagnostics Market Share by Application (2019-2030)
Figure 56. MEALA Prostate Cancer Diagnostics Market Share by Country (2019-2030)
Figure 57. Brazil Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 58. Mexico Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 59. Turkey Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 60. Israel Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 61. GCC Countries Prostate Cancer Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 62. Research Process
Figure 63. Key Executives Interviewed
